3 Reasons RGEN is Risky and 1 Stock to Buy Instead
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in...
3 Out-of-Favor Stocks We Keep Off Our Radar
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of...
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
Why Repligen (RGEN) Stock Is Trading Up Today
1 Growth Stock with Explosive Upside and 2 Facing Headwinds
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know